期刊文献+

肿瘤坏死因子α和白细胞介素6致脂肪细胞胰岛素抵抗的不同机制 被引量:5

Tumor necrosis factor-α and interleukin-6 induced insulin resistance in adipocytes via distinct mechanisms
原文传递
导出
摘要 白细胞介素6(IL-6)和肿瘤坏死因子α(TNF-α)分别作用于3T3-L1细胞6h72h,观察对葡萄糖摄取和胰岛素信号转导的影响。两者作用72h抑制胰岛素刺激的葡萄糖摄取、胰岛素受体底物1(IRS-1)酪氨酸及蛋白激酶B(PKB)磷酸化,并使IRS-1表达下降。TNF-α作用6h增加IRS-1丝氨酸307磷酸化。提示IL-6和TNF-α致胰岛素抵抗的作用机制不尽相同。 3T3-L1 adipocytes were exposed separately to TNF-α and IL-6 for 6 or 72 h and glucose uptake and insulin signaling transduction in these ceils were measured. Both IL-6 and TNF-α treatments for 72 h inhibited insulin-stimulated glucose uptake, tyrosine phosphorylations of insulin receptor substrate-1 ( IRS-1 ) and protein kinase B (PKB) phosphorylation, and IRS-1 expression. Treatment with TNF-α for 6 h had no effect on IRS-1 expression but significantly increased Serine307 phosphorylation of SRS-1. Hence, IL-6 and TNF-α may induce insulin resistance via different mechanisms.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2007年第1期77-78,共2页 Chinese Journal of Endocrinology and Metabolism
关键词 肿瘤坏死因子Α 白细胞介素6 胰岛素受体底物1 蛋白激酶B 脂细胞 胰岛素抵抗 Tumor necrosis factor-α Interleukin-6 Insulin receptor substrate-1 Protein kinase B Adipocytes Insulin resistance
  • 相关文献

参考文献7

  • 1Wellen KE,Hotamisligil GS.Inflammation,stress,and diabetes.J Clin invest,2005,115:1111-1119.
  • 2曾天舒,陈璐璐,袁莉.吡格列酮减轻肿瘤坏死因子α所致3T3-L1脂肪细胞胰岛素抵抗[J].中华糖尿病杂志(1006-6187),2005,13(6):423-425. 被引量:5
  • 3Pradhan AD,Manson JE,Rifai N,et al.C-reactive protein,interleukin-6,and risk of developing type 2 diabetes mellitus.JAMA,2001,286:327-334.
  • 4Bastard JP,Maachi M,Van Nhieu JT,et al.Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.J Clin Endocrinol Metab,2002,87:2084-2089.
  • 5Shulman GI.Cellular mechanisms of insulin resistance.J Clin Invest,2000,106:171-176.
  • 6Elchebly M,Payette P,Michaliszyn E,et al.Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1 B gene.Science,1999,283:1544-1548.
  • 7Aguirre V,Uchida T,Yenush L,et al.The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307.J Biol Chem,2000,275:9047-9054.

二级参考文献6

  • 1Olefsky JM. Treatment of insulin resistance with peroxisome proliferatoractivated receptor γ agonists. J Clin Invest, 2000, 106:467-472.
  • 2Hotamisligil. G S. Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes , 1999,107:119-125.
  • 3Shulman. G I. Cellular mechanisms of insulin resistance. J Clin Invest, 2000,106:171-176.
  • 4Hevener AL, Reichart D, Janez A. et al. Thiazolidinedione treatment prevents free fatty acid-Induced Insulin resistance in male wistar rats. Diabetes, 2001,50:2316-2322.
  • 5Meyer MM, Levin K, Grimmsmann T, et al. Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes. Diabetes, 2002,51:2691-2697.
  • 6Iwata M, Haruta T, Usui I, et al. Pioglitazone ameliorates tumor necrosis factor-a-Induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor-γ. Diabetes, 2001,50: 1083-1092.

共引文献4

同被引文献57

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部